Ethinyl estradiol, levonorgestrel drug combination
Showing 26 - 50 of >10,000
Women, Contraception Trial in Quebec City (Segesterone Acetate and Ethinyl Estradiol, Rifampin, Itraconazole)
Completed
- Women
- Contraception
- Segesterone Acetate and Ethinyl Estradiol
- +2 more
-
Quebec City, Quebec, CanadaSyneos Health
Jan 28, 2021
Diabetes, Type 2 Trial in Berlin (Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL)
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide 1.34 mg/mL
- +4 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Jan 3, 2022
Healthy Participants Trial in Cypress (BMS-986166, Oral contraceptive)
Completed
- Healthy Participants
- BMS-986166
- Oral contraceptive
-
Cypress, CaliforniaWest Coast Clinical Trials Global
Mar 7, 2022
Migraine, Migraine;Menstrual Trial in Leiden (Ethinylestradiol/levonorgestrel, Vitamin E)
Recruiting
- Migraine
- Migraine;Menstrual
- Ethinylestradiol/levonorgestrel
- Vitamin E
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Center
Apr 6, 2022
HCV Infection Trial in Christchurch (SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol)
HIV-1-infection Trial in Reutov (Elpida®, Rifampin, Rifabutin)
Completed
- HIV-1-infection
- Elpida®
- +6 more
-
Reutov, Moscow Region, Russian FederationCentral Clinical City Hospital
Jan 10, 2022
HIV Trial in Austin (GSK3640254, Portia)
Completed
- HIV Infections
-
Austin, TexasGSK Investigational Site
Aug 18, 2020
Native Estrogen Estetrol (E4) Safety Study
Recruiting
- Contraception
- Birth Control
-
Berlin, GermanyBerlin Center for Epidemiology and Health Research
Aug 31, 2023
Contraceptive Methods Comparison Trial in Istanbul (YASMIN® (Drospirenone/Ethinyl Estradiol), The Copper-T is an intrauterine
Withdrawn
- Contraceptive Methods Comparison
- YASMIN® (Drospirenone/Ethinyl Estradiol)
- +2 more
-
Istanbul, TurkeyIstanbul Training and Research Hospital
Aug 12, 2020
Contraception Trial in Portland (Cannabidiol Oil, Placebo, Combined oral contraceptive pill)
Active, not recruiting
- Contraception
- Cannabidiol Oil
- +2 more
-
Portland, OregonOHSU
Mar 31, 2022
Healthy Volunteers Trial in Tempe (CTP-543, Combined oral contraceptive containing Ethinyl estradiol (EE) and Levonorgestrel
Completed
- Healthy Volunteers
- CTP-543
- Combined oral contraceptive containing Ethinyl estradiol (EE) and Levonorgestrel (LNG)
-
Tempe, ArizonaCelerion, Inc.
Jul 14, 2020
Healthy Women, Female, Contraception Trial in Mount Royal (EVE119 vaginal ring, Nuvaring vaginal ring)
Recruiting
- Healthy Women
- +2 more
- EVE119 vaginal ring
- Nuvaring vaginal ring
-
Mount Royal, Quebec, CanadaAltasciences
Aug 8, 2023
Healthy Female Volunteers Trial in Coral Gables, Miami (PF-06700841, Ethinyl estradiol (EE) and levonorgestrel (LN))
Completed
- Healthy Female Volunteers
- PF-06700841
- Ethinyl estradiol (EE) and levonorgestrel (LN)
-
Coral Gables, Florida
- +1 more
Nov 11, 2020
Biological Availability Trial in Mannheim, Mönchengladbach (levonorgestrel/ Microlut, Norethindrone/ Noriday, Desogestrel/
Completed
- Biological Availability
- levonorgestrel/ Microlut
- +6 more
-
Mannheim, Baden-Württemberg, Germany
- +1 more
Apr 14, 2020
Healthy Trial in Merksem (JNJ-55308942 High Dose, JNJ-55308942 Low Dose, Levonorgestrel/Ethinyl Estradiol Fixed Dose combination
Completed
- Healthy
- JNJ-55308942 High Dose
- +3 more
-
Merksem, BelgiumClinical Pharmacology Unit
Sep 27, 2018
Anemia Trial (Measure hemoglobin)
Not yet recruiting
- Anemia
- Measure hemoglobin
- (no location specified)
Oct 6, 2022
Contraception, HIV Trial in Los Angeles (Levonorgestrel and Ethinyl Estradiol)
Terminated
- Contraception
- HIV
- Levonorgestrel and Ethinyl Estradiol
-
Los Angeles, CaliforniaUniversity of Southern California
May 7, 2019
Metastatic Breast Cancer Trial (Olaparib, 17b-estradiol)
Not yet recruiting
- Metastatic Breast Cancer
- (no location specified)
Jun 2, 2023
Adenomyosis, Chronic Pelvic Pain Trial (LNG-IUS 13,5 mg Levonorgestrel, Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg)
Unknown status
- Adenomyosis
- Chronic Pelvic Pain
- LNG-IUS 13,5 mg Levonorgestrel
- Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg
- (no location specified)
Feb 3, 2021
Bioequivalence Trial in Santiago (Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Dienogest 2.0 mg and Ethinyl
Completed
- Bioequivalence
- Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Test Drug
- Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Reference Product
-
Santiago, ChileInnolab
Dec 9, 2019